Bacterial Infections Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews
Cochrane Systematic Review: Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Cochrane Systematic Review: Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
- Visit
Schuetz P, Mller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, N...
Schuetz P, Mller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolf...
Objectives: The aim of this systematic review based on individual patient data was to assess the safety and efficacy of using procalcitonin for starting or stopping antibiotics over a large range of patients with varying severity of ARIs and from different clinical settings.
Objectives: The aim of this systematic review based on individual patient data was to assess the safety and efficacy of using procalcitonin for starting or stopping antibiotics over a large range of patients with varying severity of ARIs and from different clinical settings.
Cochrane Systematic Review: Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department
Cochrane Systematic Review: Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department
- Visit
Doan Q, Enarson P, Kissoon N, Klassen TP, Johnson DW.
Doan Q, Enarson P, Kissoon N, Klassen TP, Johnson DW.
Objectives: To determine the effect of rapid viral testing in the ED on the rate of precautionary testing, antibiotic use, and length of ED visit.
Objectives: To determine the effect of rapid viral testing in the ED on the rate of precautionary testing, antibiotic use, and length of ED visit.
Cochrane Systematic Review: Macrolide antibiotics for cystic fibrosis
Cochrane Systematic Review: Macrolide antibiotics for cystic fibrosis
- Visit
Southern KW, Barker PM, Solis-Moya A, Patel L
Southern KW, Barker PM, Solis-Moya A, Patel L
OBJECTIVES: To test the hypotheses that, in people with cystic fibrosis, macrolide antibiotics: 1. improve clinical status compared to placebo or another antibiotic; 2. do not have unacceptable adverse effects. If benefit was demonstrated, we aimed to assess the optimal type, dose and duration of macrolide therapy.
OBJECTIVES: To test the hypotheses that, in people with cystic fibrosis, macrolide antibiotics: 1. improve clinical status compared to placebo or another antibiotic; 2. do not have unacceptable adverse effects. If benefit was demonstrated, we aimed to assess the optimal type, dose and duration of macrolide therapy.
Cochrane Systematic Review: Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
Cochrane Systematic Review: Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
- Visit
Hurley MN, Forrester DL, Smyth AR
Hurley MN, Forrester DL, Smyth AR
OBJECTIVES: To determine if antibiotic adjuvants improve clinical and microbiological outcome of pulmonary infection in people with cystic fibrosis.
OBJECTIVES: To determine if antibiotic adjuvants improve clinical and microbiological outcome of pulmonary infection in people with cystic fibrosis.
Cochrane Systematic Review: Antibiotics for otitis media with effusion in children
Cochrane Systematic Review: Antibiotics for otitis media with effusion in children
- Visit
van Zon A, van der Heijden GJ, van Dongen TM, Burton MJ, Schilder AG
van Zon A, van der Heijden GJ, van Dongen TM, Burton MJ, Schilder AG
OBJECTIVES: To assess the effects of antibiotics in children up to 18 years with OME.
OBJECTIVES: To assess the effects of antibiotics in children up to 18 years with OME.
Cochrane Systematic Review: Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Cochrane Systematic Review: Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
- Visit
Schuetz P, Mller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, N...
Schuetz P, Mller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolf...
Objectives: The aim of this systematic review based on individual patient data was to assess the safety and efficacy of using procalcitonin for starting or stopping antibiotics over a large range of patients with varying severity of ARIs and from different clinical settings.
Objectives: The aim of this systematic review based on individual patient data was to assess the safety and efficacy of using procalcitonin for starting or stopping antibiotics over a large range of patients with varying severity of ARIs and from different clinical settings.
Cochrane Systematic Review: Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department
Cochrane Systematic Review: Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department
- Visit
Doan Q, Enarson P, Kissoon N, Klassen TP, Johnson DW.
Doan Q, Enarson P, Kissoon N, Klassen TP, Johnson DW.
Objectives: To determine the effect of rapid viral testing in the ED on the rate of precautionary testing, antibiotic use, and length of ED visit.
Objectives: To determine the effect of rapid viral testing in the ED on the rate of precautionary testing, antibiotic use, and length of ED visit.
Cochrane Systematic Review: Macrolide antibiotics for cystic fibrosis
Cochrane Systematic Review: Macrolide antibiotics for cystic fibrosis
- Visit
Southern KW, Barker PM, Solis-Moya A, Patel L
Southern KW, Barker PM, Solis-Moya A, Patel L
OBJECTIVES: To test the hypotheses that, in people with cystic fibrosis, macrolide antibiotics: 1. improve clinical status compared to placebo or another antibiotic; 2. do not have unacceptable adverse effects. If benefit was demonstrated, we aimed to assess the optimal type, dose and duration of macrolide therapy.
OBJECTIVES: To test the hypotheses that, in people with cystic fibrosis, macrolide antibiotics: 1. improve clinical status compared to placebo or another antibiotic; 2. do not have unacceptable adverse effects. If benefit was demonstrated, we aimed to assess the optimal type, dose and duration of macrolide therapy.
Cochrane Systematic Review: Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
Cochrane Systematic Review: Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
- Visit
Hurley MN, Forrester DL, Smyth AR
Hurley MN, Forrester DL, Smyth AR
OBJECTIVES: To determine if antibiotic adjuvants improve clinical and microbiological outcome of pulmonary infection in people with cystic fibrosis.
OBJECTIVES: To determine if antibiotic adjuvants improve clinical and microbiological outcome of pulmonary infection in people with cystic fibrosis.
Cochrane Systematic Review: Antibiotics for otitis media with effusion in children
Cochrane Systematic Review: Antibiotics for otitis media with effusion in children
- Visit
van Zon A, van der Heijden GJ, van Dongen TM, Burton MJ, Schilder AG
van Zon A, van der Heijden GJ, van Dongen TM, Burton MJ, Schilder AG
OBJECTIVES: To assess the effects of antibiotics in children up to 18 years with OME.
OBJECTIVES: To assess the effects of antibiotics in children up to 18 years with OME.
